Mikart, LLC, a US-based Contract Development and Manufacturing Organisation (CDMO), announced on Thursday that it has added Fette double-sided tablet presses to increase its production capacity and meet the product demands of its increasing number of customers.
The tablet presses have advanced features, which include automatic weight control, metal detectors, dedusters and bulk powder feeding systems for optimal efficiency and precision of tablet production applications.
Michael Kallelis, Mikart, LLC CEO, said, 'We are thrilled to expand our Fette tablet press platforms into our manufacturing operations. These high-speed and high-volume presses mark a significant milestone in our journey towards enhancing client satisfaction and accommodating the growing brand and generic market.'
Zydus Lifesciences signs licensing and supply agreement with Viwit Pharmaceuticals
Hikma Pharmaceuticals extends KLOXXADO nasal spray shelf-life 8mg from 24 to 36 months
Sun Pharma's LEQSELVI 8mg tablets receive US FDA approval